Meladze N.V.1, Ustyuzhanin D.V.1, Ternovoy S.K.1,2,

Shariya A.M.1, Gaman S.A.1

Purpose. To demonstrate the effectiveness of computed tomography (CT) in lung damage monitoring and the treatment assessment of viral pneumonia caused by the new SARS-CoV-2 coronavirus (Severe Acute Respiratory Syndrome CoronaVirus 2).

Materials and methods. 56-year-old patient K. with complaints of fever up to 38.5° C, wet cough, severe weakness, shortness of breath, feeling of tightness in the chest, loss of smell and taste underwent general and biochemical blood tests, performed pulse oximetry, CT of the chest organs, analysis for the detection of SARS-CoV-2 virus RNA by polymerase chain reaction (PCR).

Results. Viral COVID-19 pneumonia was detected and confirmed by CT of the chest in a patient with a primary negative test on the SARS-CoV-2 virus. CT allowed to evaluate the effectiveness of the therapy and choose the most optimal treatment, which led to a decrease in the volume of lung damage and further complete recovery.

Conclusion. CT is a highly informative method for evaluation of lung damage dynamics in patients with viral pneumonia caused by SARS-CoV-2 coronavirus that allowed to assess the effectiveness of the therapy in patients with lung damage in pneumonia caused by SARS-CoV-2.


1 -  Institute of Clinical Cardiology, National Medical Research Center of Cardiology.

2 - Sechenov First

Moscow State Medical University (Sechenov University).

Moscow, Russia.

Keywords: coronavirus, SARS-CoV-2, COVID-19, viral pneumonia, CT of the lungs.


Corresponding author:  Meladze N.V., e-mail: Этот e-mail адрес защищен от спам-ботов, для его просмотра у Вас должен быть включен Javascript


For citation: Meladze N.V., Ustyuzhanin D.V., Ternovoy S.K., Shariya A.M., Gaman S.A. Lung damage monitoring by computed tomography in typical coronavirus disease. REJR 2020; 10(3):15-19. DOI:10.21569/2222-7415-2020-10-3-15-19.


Received: 17.07.20 Accepted:     28.08.20